ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
다우존스 지수
44,910.65
0.42%
Bitcoin
96,172.58
-0.27%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. CRISPR Therapeutics AG (CRSP)

  7. CRISPR Therapeutics AG (CRSP) 뉴스

CRSP

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics AG
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CRSP
일자시간출처헤드라인심볼기업
2024/11/1422:30GlobeNewswire Inc.CRISPR Therapeutics to Present at the Jefferies London Healthcare ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
2024/11/1407:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/11/0722:00GlobeNewswire Inc.CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
2024/11/0523:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRSPCRISPR Therapeutics AG
2024/11/0523:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
2024/11/0523:01GlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1906:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1906:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1906:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1906:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1906:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1607:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/10/1607:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/08/1307:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/08/0606:22Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:CRSPCRISPR Therapeutics AG
2024/08/0605:54Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRSPCRISPR Therapeutics AG
2024/08/0605:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRSPCRISPR Therapeutics AG
2024/08/0605:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
2024/08/0605:01GlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
2024/06/0321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
2024/06/0105:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/06/0105:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/06/0105:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/3105:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/3005:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/2921:00GlobeNewswire Inc.CRISPR Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/2505:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/2405:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/2321:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
2024/05/2321:00GlobeNewswire Inc.CRISPR Therapeutics Strengthens Executive Leadership Team with Key AppointmentsNASDAQ:CRSPCRISPR Therapeutics AG
 검색 관련기사 보기:NASDAQ:CRSP

최근 히스토리

CCOM
US30
US 30
NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
GOOGL
Alphabet
NYSE
NKE
Nike
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
COIN
DOGEUSD
Dogecoin
COIN
AVAXUSD
Avalanche
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유